Pilot Study of Imatinib Cetuximab Combo for H & N Cancer
Condition(s):Head and Neck Cancer; Squamous Cell Carcinoma of Head and NeckLast Updated:March 8, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Head and Neck Cancer; Squamous Cell Carcinoma of Head and NeckLast Updated:March 8, 2024Recruiting
Condition(s):Chronic Myelogenous LeukemiaLast Updated:September 7, 2016Terminated
Condition(s):Mesothelioma, MalignantLast Updated:January 22, 2021Completed
Condition(s):Acute Ischaemic StrokeLast Updated:September 16, 2020Unknown status
Condition(s):SarcomaLast Updated:November 9, 2023Active, not recruiting
Condition(s):COVID-19Last Updated:June 9, 2020Unknown status
Condition(s):Progression-free Survival; Gastrointestinal Stromal Tumor; NeoadjuvantLast Updated:October 12, 2021Recruiting
Condition(s):DermoidLast Updated:January 23, 2024Recruiting
Condition(s):ALK+ Anaplastic Large Cell LymphomaLast Updated:March 3, 2022Terminated
Condition(s):Gastrointestinal Stromal Tumor, MalignantLast Updated:October 18, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.